The management of prostate cancer in patients with a rising prostate-specific antigen level.
Fichtner
J
J
Department of Urology, Mainz University Medical School, Mainz, Germany.fichtner@mail.uni-mainz.de
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000628:therapy*; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen